Back to Search Start Over

Coronavirus disease 2019 (COVID-19), MERS and SARS: Similarity and difference

Authors :
Zeinab Mohseni Afshar
Soheil Ebrahimpour
Mostafa Javanian
Veerendra Koppolu
Veneela Krishna Rekha Vasigala
Amir Hossein Hasanpour
Arefeh Babazadeh
Source :
Journal of Acute Disease, Vol 9, Iss 5, Pp 194-199 (2020)
Publication Year :
2020
Publisher :
Wolters Kluwer Medknow Publications, 2020.

Abstract

SARS-CoV-2 is the causative agent of COVID-19. Since its outbreak in December 2019, COVID-19 has swept the globe. By 17 July 2020, the World Health Organization (WHO) had confirmed 13 119 239 cases and 573 752 deaths, and the numbers are still rising. Current evidence shows that COVID-19 is lower than severe acute respiratory syndrome and Middle East respiratory syndrome in terms of severity and mortality risk, although the infections are particularly more severe in patients with underlying medical conditions. The bulk of COVID-19 patients had close contact with confirmed cases, but an exact origin and specific transmission for COVID-19 are still unknown. As there is no approved antiviral treatment for COVID-19 infection, proper prevention and control practices are essential to control the infection. To have an insight view of COVID-19, we summarized and compared the etiology, clinical manifestations, diagnosis, treatment, and prevention measures of COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome.

Details

Language :
English
ISSN :
22216189 and 25895516
Volume :
9
Issue :
5
Database :
Directory of Open Access Journals
Journal :
Journal of Acute Disease
Publication Type :
Academic Journal
Accession number :
edsdoj.1c616dc2403f44039ef97997831038a1
Document Type :
article
Full Text :
https://doi.org/10.4103/2221-6189.291283